Estee Lauder Companies Inc (NYSE:EL) stock rose 2.08% (As on August 21, 11:29:51 AM UTC-4, Source: Google Finance) though the company’s fiscal year 2026 outlook fell short of expectations amid tariffs and consumer weakness in its major markets. Adjusted Gross margin expanded 230 basis points, to 74.0%, despite the decline in net sales, primarily driven by net benefits from the Company’s Profit Recovery and Growth Plan (“PRGP”) through operational efficiencies, lower excess and obsolescence and benefits from our strategic pricing actions. Adjusted operating margin contracted 220 basis points, to 8.0% from 10.2%. This reflects the increase in consumer-facing investments, along with sales volume deleverage in fiscal 2025. These impacts were partially offset by net benefits from the Company’s PRGP that helped to reduce non-consumer-facing expenses. Net cash flows provided by operating activities decreased to $1.27 billion, compared with $2.36 billion in the prior year, primarily reflecting lower pre-tax earnings, excluding non-cash items, as well as the unfavorable change in operating assets and liabilities. Capital expenditures decreased to $602 million from $919 million in the prior year, primarily due to the prior-year payments relating to the manufacturing facility in Japan.
Moreover, the company extended halos of beloved franchises, including (i) Estée Lauder Re-Nutriv Ultimate Diamond Age Reversal Eye Creme and Double Wear Stay-in-Place 24-Hour Concealer, and (ii) fiscal 2025 fourth-quarter launches, such as La Mer The New Balancing Treatment Lotion and Clinique Almost Lipstick in Nude Honey. The company elevated nighttime usage occasions within the moisturizer and serum subcategories with La Mer The Night Recovery Concentrate and The New Rejuvenating Night Cream.
EL in the fourth quarter of FY25 has reported the adjusted earnings per share of 9 cents, beating the analysts’ estimates for the adjusted earnings per share of 8 cents. The company had reported the adjusted revenue decline of 8 percent to $3.41 billion in the fourth quarter of FY25, missing the analysts’ estimates for revenue of $3.5 billion.
The company said it expects adjusted earnings per share (EPS) in the range of $1.90 to $2.10, below Street forecasts of $2.21. The company said it expects tariffs to have an impact of approximately $100 million on its fiscal 2026 profitability. Organic sales growth is expected to be flat to up 3%. Despite continued volatility in the external environment, the company embarked on fiscal 2026 with signs of momentum and confidence in the outlook to deliver organic sales growth this year after three years of declines and to begin rebuilding operating profitability in pursuit of a solid double-digit adjusted operating margin over the next few years.